Biohit Oyj (LTS:0DRP) Short Percentage of Float


LTS:0DRP Biohit Oyj LTS:0DRP
78 GF Score
Price €2.47
GF Value €2.76
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Biohit Oyj Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LTS:0DRP vs ABT, SYK, MDT: Short Percentage of Float Comparison

For the Medical Devices subindustry, Biohit Oyj's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biohit Oyj Short Percentage of Float vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biohit Oyj's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Biohit Oyj's Short Percentage of Float falls into.


LTS:0DRP
78GF Score
Biohit Oyj LTS:0DRP
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biohit Oyj (LTS:0DRP) Overvalued in 2026?

Based on GuruFocus' analysis, Biohit Oyj stock appears to be undervalued. The current stock price of €2.47 is trading 10.5% below its estimated GF Value™ of €2.76. GuruFocus considers Biohit Oyj to be Modestly Undervalued.

Key valuation signals for LTS:0DRP:

  • Short Percentage of Float:
  • GF Value™: €2.76 vs. price of €2.47 (10.5% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the LTS:0DRP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biohit Oyj Business Description

Other Exchanges BIOBV:Finland
Address Laippatie 1, Helsinki, FIN, 00880
Biohit Oyj is a globally operating Finnish biotechnology company that develops diagnostic and other health products. Its products include GastroPanel quick test assesses the structure and function of the stomach lining; ColonView quick test is an immunochemical fecal occult blood test (FIT) developed; Acetium capsules protect the stomach lining from carcinogenic acetaldehyde, especially in people with acid-free stomachs. The company's product portfolio consists of diagnostic tests, analysis systems, products binding carcinogenic acetaldehyde into a harmless compound and monoclonal antibodies.
78GF Score

Get the complete analysis for LTS:0DRP

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.47
Price
€2.76
GF Value